GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Price-to-Operating-Cash-Flow

ProKidney (MEX:PROK) Price-to-Operating-Cash-Flow : (As of Jun. 22, 2024)


View and export this data going back to 2022. Start your Free Trial

What is ProKidney Price-to-Operating-Cash-Flow?

As of today (2024-06-22), ProKidney's share price is MXN47.60. ProKidney's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was MXN-27.05. Hence, ProKidney's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for ProKidney's Price-to-Operating-Cash-Flow or its related term are showing as below:

MEX:PROK's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.48
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

ProKidney's Cash Flow from Operations per share for the three months ended in Mar. 2024 was MXN-9.43. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was MXN-27.05.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -121.10% per year.

During the past 4 years, ProKidney's highest 3-Year average Operating Cash Flow per Share Growth Rate was -121.10% per year. The lowest was -121.10% per year. And the median was -121.10% per year.


ProKidney Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ProKidney's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Price-to-Operating-Cash-Flow Chart

ProKidney Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - - -

ProKidney Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ProKidney's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, ProKidney's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProKidney's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProKidney's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ProKidney's Price-to-Operating-Cash-Flow falls into.



ProKidney Price-to-Operating-Cash-Flow Calculation

ProKidney's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=47.60/-27.051
=

ProKidney's Share Price of today is MXN47.60.
ProKidney's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-27.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

ProKidney Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ProKidney's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ProKidney (MEX:PROK) Business Description

Industry
Traded in Other Exchanges
Address
2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.